Detrimental effect of atazanavir plasma concentrations on total serum bilirubin levels in the presence of UGT1A1 polymorphisms

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):e96-7. doi: 10.1097/QAI.0b013e318203e7e7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / adverse effects*
  • Atazanavir Sulfate
  • Bilirubin / blood*
  • Female
  • Glucuronosyltransferase / genetics*
  • Humans
  • Male
  • Middle Aged
  • Oligopeptides / adverse effects*
  • Plasma / chemistry*
  • Polymorphism, Genetic*
  • Pyridines / adverse effects*

Substances

  • Anti-HIV Agents
  • Oligopeptides
  • Pyridines
  • Atazanavir Sulfate
  • UGT1A1 enzyme
  • Glucuronosyltransferase
  • Bilirubin